B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha - PubMed (original) (raw)
Comparative Study
B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha
M M Swallow et al. Immunity. 1999 Oct.
Free article
Abstract
In a screen to identify genes induced by NF-kappaB/Rel transcription factors, we cloned a novel gene, b7h, that is a close homolog of B7 costimulatory ligands expressed on antigen-presenting cells. B7h can costimulate proliferation of purified T cells through a receptor on T cells distinct from CD28 or CTLA-4. Surprisingly, although B7h is expressed in unstimulated B cells, its expression is induced in both 3T3 cells and embryonic fibroblasts treated with TNFalpha, and it is upregulated in nonlymphoid tissues of mice treated with LPS, a potent activator of TNFalpha. These data define a novel costimulatory ligand for T cells and suggest that induction of B7h by TNFalpha may function as a mechanism to directly augment recognition of self during inflammation.
Similar articles
- ICOS-induced B7h shedding on B cells is inhibited by TLR7/8 and TLR9.
Logue EC, Bakkour S, Murphy MM, Nolla H, Sha WC. Logue EC, et al. J Immunol. 2006 Aug 15;177(4):2356-64. doi: 10.4049/jimmunol.177.4.2356. J Immunol. 2006. PMID: 16887997 - Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.
Freeman GJ, Gribben JG, Boussiotis VA, Ng JW, Restivo VA Jr, Lombard LA, Gray GS, Nadler LM. Freeman GJ, et al. Science. 1993 Nov 5;262(5135):909-11. doi: 10.1126/science.7694363. Science. 1993. PMID: 7694363 - Regulation of immune and autoimmune responses by ICOS-B7h interaction.
Nurieva RI. Nurieva RI. Clin Immunol. 2005 Apr;115(1):19-25. doi: 10.1016/j.clim.2005.02.010. Clin Immunol. 2005. PMID: 15870016 Review. - T cells: A proliferation of costimulatory molecules.
Mueller DL. Mueller DL. Curr Biol. 2000 Mar 23;10(6):R227-30. doi: 10.1016/s0960-9822(00)00400-0. Curr Biol. 2000. PMID: 10744968 Review.
Cited by
- BAP31 Plays an Essential Role in Mouse B Cell Development via Regulation of BCR Signaling.
Zhao B, An F, Hao Z, Zhang W, Wang B. Zhao B, et al. Int J Mol Sci. 2024 May 2;25(9):4962. doi: 10.3390/ijms25094962. Int J Mol Sci. 2024. PMID: 38732181 Free PMC article. - Influence of Microbiota on Tumor Immunotherapy.
Yu X, Li W, Li Z, Wu Q, Sun S. Yu X, et al. Int J Biol Sci. 2024 Mar 31;20(6):2264-2294. doi: 10.7150/ijbs.91771. eCollection 2024. Int J Biol Sci. 2024. PMID: 38617537 Free PMC article. Review. - Deep Flow Cytometry Unveils Distinct Immune Cell Subsets in Inducible T Cell Co-Stimulator Ligand (ICOSL)- and ICOS-Knockout Mice during Experimental Autoimmune Encephalomyelitis.
Raineri D, Abreu H, Vilardo B, Kustrimovic N, Venegoni C, Cappellano G, Chiocchetti A. Raineri D, et al. Int J Mol Sci. 2024 Feb 21;25(5):2509. doi: 10.3390/ijms25052509. Int J Mol Sci. 2024. PMID: 38473756 Free PMC article. - Engaging stimulatory immune checkpoint interactions in the tumour immune microenvironment of primary liver cancers - how to push the gas after having released the brake.
Rakké YS, Buschow SI, IJzermans JNM, Sprengers D. Rakké YS, et al. Front Immunol. 2024 Feb 19;15:1357333. doi: 10.3389/fimmu.2024.1357333. eCollection 2024. Front Immunol. 2024. PMID: 38440738 Free PMC article. Review. - First-in-class small molecule inhibitors of ICOS/ICOSL interaction as a novel class of immunomodulators.
Abdel-Rahman SA, Świderek K, Gabr MT. Abdel-Rahman SA, et al. RSC Med Chem. 2023 Aug 1;14(9):1767-1777. doi: 10.1039/d3md00150d. eCollection 2023 Sep 19. RSC Med Chem. 2023. PMID: 37731692 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials